Darius N. Lakdawalla, PhD

Professor of Pharmaceutical and Health Economics & Quintiles Chair in Pharmaceutical Development and Regulatory Innovation · USC School of Pharmacy

Darius Lakdawalla is a widely published, award-winning researcher and a leading authority in both health economics and health policy.

Health Economics Health Policy Economics Medicines Health Care

Joel W. Hay, PhD

Professor of Pharmaceutical and Health Economics · USC School of Pharmacy

Joel Hay's research focuses on pharmacoeconomics, outcomes research, pharmaceutical care, health economics and econometrics.

Econometrics Drug Legalization Pharmaceutical Economics Health Economics Outcomes Research

Jan D. Hirsch

Founding Dean, School of Pharmacy and Pharmaceutical Sciences · UC Irvine

Jan Hirsch's research interests are focused in the areas of pharmacoeconomics and outcomes research.

Comprehensive Medication Management (CMM) Medication Therapy Management Clinical Pharmacy Pharmacoeconomics Drug Development

John A. Romley, PhD

Associate Professor of Pharmaceutical and Health Economics · USC School of Pharmacy

John Romley is an expert in health care costs, public health, and health insurance markets and benefits design.

Behavioral Economics Pharmacoeconomics Medical Innovation & Regulatory Policy Public Health Health Care Costs

Peter O'Blenis

COO · Flick Software Inc

Enterprise Mobile Apps and IT in Health Care Research

Mobile Business Solutions: Extending Business Applications Beyond the Desktop Use of Software in Systematic Reviews to Produce High Quality Results Much More Faster. Starting and Growing A Software Business in Canada

Lizheng Shi

Endowed Regents Professor and vice chair of health policy and management · Tulane University

Lizheng Shi is an expert in health technology assessment, economics and policy, and for COVID-19.

Coronavirus Health Policy health technology assessment Health Economics COVID-19